Features
Med Mal News
A collection of the most important news you need to know.
Nanotechnology
In the past, and even now to some extent, many medicinal substances were used because they seemed to work, even though the specific mechanism, pharmacology or pharmacodynamics were not precisely understood. That is part of the reason for the lengthy and complex new drug approval process through the FDA.
Breast Cancer Claims
As breast cancer screening evolves in the digital age, so do the issues confronting lawyers. Here's why.
Features
Upcoming Events
Texas Bar 19th Annual Entertainment Law Institute<br>American Bar Association Forum on the Entertainment and Sports Industries Annual Meeting
Bit Parts
Alleged Oral Copyright License No Bar to Infringement Suit<br>Musical Compositions' Valuation Upheld<br>Song Suit Against Destiny's Child Sent to Trial
Cameo Clips
COPYRIGHT JURISDICTION/ REGISTRATION REQUIRED<br>COPYRIGHT OWNERSHIP/JOINT AUTHORS<br>KARAOKE RECORDINGS/COPYRIGHT DAMAGES<br>WEB SITE OPERATORS/PERSONAL JURISDICTION
Single-Publication Rule Applies to Publicity Claim
In a limited victory for publishers, the California Supreme Court ruled on Aug. 17 that the state's single-publication rule applies to the tort of appropriation of likeness. Christoff v. Nestl' USA, Inc., S155242. The ruling came in the case of a model who said Nestle USA used his face ' without his knowledge ' to sell Taster's Choice instant coffee for years.
Motown Magic Sues Willkie Farr for Fraud, Breach of Contract
Willkie Farr & Gallagher has been sued in federal court in Los Angeles by Lamont Dozier, the cofounder of songwriting and production team Holland-Dozier-Holland, which was behind hit Motown acts like The Supremes and The Isley Brothers. At issue: Willkie's role advising on an issuance of Bowie Bonds, the asset-backed security for song royalties sometimes called Pullman Bonds because they were popularized by the banker David Pullman, now chairman and CEO of The Pullman Group in New York.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›